Repligen Announced The Commercial Launch Of TangenX SC, The Industry's First Holder-free, Self-contained Tangential Flow Filtration Device
Portfolio Pulse from Benzinga Newsdesk
Repligen Corporation has announced the commercial launch of TangenX SC, the industry's first holder-free, self-contained tangential flow filtration device. This innovative product is expected to revolutionize the bioprocessing industry.
November 02, 2023 | 11:56 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Repligen's launch of TangenX SC, a unique product in the bioprocessing industry, could potentially boost the company's market position and revenues.
The launch of a unique and innovative product like TangenX SC could potentially increase Repligen's market share in the bioprocessing industry. This could lead to increased revenues and a positive impact on the company's stock price in the short term.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100